about
Targeted Therapy in Biliary Tract CancersInnovation in catheter design for intra-arterial liver cancer treatments results in favorable particle-fluid dynamics.Synchronous double primary squamous cell carcinoma and adenocarcinoma of the extrahepatic bile duct: a case reportOleanolic acid induces mitochondrial-dependent apoptosis and G0/G1 phase arrest in gallbladder cancer cells.Long-Term Outcomes and Prognostic Factors in Advanced Gallbladder Cancer: Focus on the Advanced T Stage.Gallbladder Carcinoma, the Difficulty of Early Detection: A Case Report.Zinc finger X-chromosomal protein (ZFX) is a significant prognostic indicator and promotes cellular malignant potential in gallbladder cancer.Increasing mortality in the United States from cholangiocarcinoma: an analysis of the National Center for Health Statistics DatabaseRates and patterns of recurrence after curative intent resection for gallbladder cancer: a multi-institution analysis from the US Extra-hepatic Biliary Malignancy ConsortiumMortality-related risk factors and long-term survival after 4460 liver resections in Sweden-a population-based study.Intrahepatic cholangiocarcinoma: current perspectives.The clinical significance and underlying correlation of pStat-3 and integrin αvβ6 expression in gallbladder cancerImmunotherapy of biliary tract cancer.The role of microRNAs in gallbladder cancer.Systemic treatment in advanced biliary cancers: A multicenter Australian analysis and review.Biliary cancer: Utility of next-generation sequencing for clinical management.Surgical Site Infection Is Associated with Tumor Recurrence in Patients with Extrahepatic Biliary Malignancies.Decision of surgical approach for advanced gallbladder adenocarcinoma based on a Bayesian network.Evaluating the Clinical Applicability of the European Staging System for Perihilar Cholangiocarcinoma.Feasibility and efficacy of gemcitabine plus cisplatin combination therapy after curative resection for biliary tract cancer.Epithelial-to-mesenchymal transition in gallbladder cancer: from clinical evidence to cellular regulatory networks.Survival after resection of perihilar cholangiocarcinoma in patients with lymph node metastases.BRCA-associated pancreatico-biliary neoplasms: Four cases illustrating the emerging clinical impact of genotyping.Synchronous cancers of gallbladder carcinoma and combined hepatocellular cholangiocarcinoma: an unusual case and literature review
P2860
Q26798443-8B0F60E6-7447-441A-8F9B-2CD950259F79Q30659636-9E2A35F0-8344-4F6C-9442-6688A5C27415Q35676386-9ED4111B-3D50-4918-A623-5C732BCE9924Q35755011-284AE9F6-E240-4CF3-B734-E25FB6FE6625Q36192862-472E430A-70D7-488D-A282-DBA3140B0BD9Q36689250-3B115C47-9D9A-4A71-8689-950729A506BFQ36838976-3D5FF49A-9987-4271-BED3-38F262970A87Q37272833-4351BCCF-95CE-405D-9EAE-D36A78D05E5FQ37391705-B8560619-A67C-47FB-8A23-77C846E1070EQ37642090-1D8B682B-30ED-4F31-9AB2-314822914FD9Q37669928-493556EB-7742-426B-9A71-26CCF06C119EQ37746036-10B5247B-F7A6-4594-A92D-740FABF96625Q38686339-EB82F24C-4454-4349-AA9D-884434B53478Q38872859-8AEE668F-4C0D-4A1C-ABAB-A5D08AADEDA3Q39012507-D4E62392-BB16-4851-B635-8669EB3E570FQ39396785-4616415E-DA33-49FC-BBA4-72FD09E43A60Q40044470-529B024B-71F8-4E0C-B1E4-DB0FE62FA802Q40055998-329779EF-4A36-466B-BD23-BA0A24845C9BQ40071866-A3F0E099-B6B7-4ACB-8EB9-A1CB77B237CCQ41521606-A15A67B1-BE23-4DED-95DA-4E7F45464E1FQ47124460-C667CAB6-5FC7-485F-A0DA-E8E91B03A851Q53263862-E80D114B-2EDD-4665-90C4-A622C3983A97Q53495668-C0F726A9-821B-4847-9C68-490387008048Q58101146-2889EB51-27BF-41D8-AE00-26A1CDBF1491
P2860
description
2014 nî lūn-bûn
@nan
2014年の論文
@ja
2014年論文
@yue
2014年論文
@zh-hant
2014年論文
@zh-hk
2014年論文
@zh-mo
2014年論文
@zh-tw
2014年论文
@wuu
2014年论文
@zh
2014年论文
@zh-cn
name
Outcomes in biliary malignancy.
@en
type
label
Outcomes in biliary malignancy.
@en
prefLabel
Outcomes in biliary malignancy.
@en
P2860
P356
P1476
Outcomes in biliary malignancy.
@en
P2093
Bas Groot Koerkamp
P2860
P304
P356
10.1002/JSO.23762
P50
P577
2014-10-01T00:00:00Z